Athersys Company Profile

11:53 EDT 25th July 2016 | BioPortfolio

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.
As represented by its name, (Athersys - derived from advanced therapeutic systems), the Company is committed to developing novel therapeutic products that deliver substantial improvements over existing therapies through the application and utilization of its advanced, proprietary technology platforms.

Through internal development and acquisition of key technologies, Athersys has established a unique blend of competencies in areas such as molecular biology, cell biology, genomics, protein biochemistry, medicinal chemistry, and pharmacology. The Company has fully integrated pre-clinical drug discovery and development capabilities, and is focused on advancing a portfolio of therapeutic development programs into the clinic.


3201 Carnegie Avenue
United States of America


Phone: 216-431-9900
Fax: 216-361-9495

News Articles [26 Associated News Articles listed on BioPortfolio]

Athersys (ATHX) - A bigger, better Japanese partnership

Edison Investment Research - Pharmaceutical & Healthcare - Athersys: Athersys has made progress on a number of clinical and commercial fronts in the first months of 2016. Most recently, it reported a ...

Athersys (ATHX) - On track for a big Japanese trial

Edison Investment Research - Pharmaceutical & Healthcare - Athersys: Athersys and its Japanese development partner Healios are on track to begin a 150-200 patient registration trial for MultiStem in s...

Athersys Inc. Announces Positive Phase 2 Stroke Results

On Thursday Feb 18th in after-hours trade, shares of Athersys (NASDAQ:ATHX) were up 21% after the company announced positive phase 2 results for its Stroke trial. The phase 2 trial had two different p...

Athersys and Healios Announce R&D Day

CLEVELAND and TOKYO, Jan. 26, 2016 (GLOBE NEWSWIRE) -- HEALIOS K.K. (“Healios”) (Tokyo Stock Exchange:4593) and Athersys, Inc. (“Athersys”) (NASDAQ:ATHX) announced today that the companie...

Athersys, Healios deal

Athersys Reports First Quarter 2016 Results

CLEVELAND, May 05, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended March 31, 2016. Highlights of the first quarter of 2016...

Athersys Joins Russell 3000® Index

CLEVELAND, June 27, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has joined the broad-market Russell 3000® Index as of the conclusion of the Russell U.S. Indices...

Athersys: Acute Respiratory Distress Syndrome Play

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]


Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.As represented by its name, (Ather...

Athersys Incorporated

Athersys is a biotechnology company engaged in the research and development of products for the treatment and diagnosis of genetic and immunologic disorders. The company has a core expertise in the f...

Athersys, Inc.

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company ...

More Information about "Athersys" on BioPortfolio

We have published hundreds of Athersys news stories on BioPortfolio along with dozens of Athersys Clinical Trials and PubMed Articles about Athersys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Athersys Companies in our database. You can also find out about relevant Athersys Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Corporate Database Quicklinks

Searches Linking to this Company Record